US Broker Ratings

Labcorp Holdings Inc. (LH) Stock Analysis: A 17% Potential Upside and Strong Buy Ratings Stand Out

Labcorp Holdings Inc. (NYSE: LH) is a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $21.8..

Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 27.91% Potential Upside for Investors

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is capturing investor attention with a compelling potential upside of 27.91% according to recent..

Sanofi (SNY) Stock Analysis: Exploring a 29% Potential Upside Amid Strategic Collaborations

Sanofi (NASDAQ: SNY), a titan in the healthcare sector and a leading figure in the Drug Manufacturers – General industry, is making waves with a substantial..

GSK plc (GSK) Stock Analysis: Evaluating a Solid 10.87% Potential Upside with a Strong Dividend Yield

GSK plc (GSK), a prominent name in the healthcare sector, has long been a stalwart in the drug manufacturing industry. With a robust market capitalization of..

Boston Scientific Corporation (BSX) Stock Analysis: Unveiling a 47.5% Upside Potential in the Medical Device Industry

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence in the medical devices..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 43.93% Potential Upside in Biotech

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its innovative approach and robust pipeline..

The Cigna Group (CI) Stock Analysis: Exploring a 28.90% Upside Potential in Healthcare Plans

The Cigna Group (NYSE: CI) stands as a formidable player in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $70.21..

Thermo Fisher Scientific Inc (TMO): Investor Outlook on a Potential 39.96% Upside

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a titan in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

AbbVie Inc. (ABBV) Stock Analysis: Unpacking a 21.49% Potential Upside Amid Healthcare Innovations

AbbVie Inc. (ABBV) stands as a formidable player in the healthcare sector, leveraging a robust portfolio of biopharmaceutical products and therapies. Incorporated in 2012 and headquartered..

Cencora, Inc. (COR) Stock Analysis: Exploring a 25% Potential Upside and Robust Revenue Growth in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a formidable player in the medical distribution industry, has been attracting attention from investors due to its promising financial metrics and growth..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 35% Potential Upside Amidst Healthcare Expansion

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, continues to carve out a formidable presence in the healthcare plans industry. Headquartered in Woonsocket,..

McKesson Corporation (MCK) Stock Analysis: Exploring the Potential 12.62% Upside for Investors

McKesson Corporation (NYSE: MCK) stands as a formidable player in the healthcare sector, operating primarily within the medical distribution industry. With a robust market capitalization of..

Eli Lilly and Company (LLY) Stock Analysis: Healthcare Giant Offers 33% Upside Potential

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, is catching the eye of investors with its impressive growth metrics and promising future..

Danaher Corporation (DHR) Stock Analysis: Navigating a 39.90% Potential Upside

Danaher Corporation (NYSE: DHR) stands as a stalwart in the healthcare sector, specifically within the Diagnostics & Research industry. With a robust market capitalization of $133.9..

Johnson & Johnson (JNJ) Stock Analysis: Revenue Growth Surges Amidst Healthcare Innovation

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to command investor attention with its formidable market capitalization of $567.22 billion. As a..

Novo Nordisk A/S (NVO) Investor Outlook: Exploring a 27.85% Upside Potential in the Healthcare Sector

Novo Nordisk A/S (NVO), a global leader in the healthcare sector, presents a compelling case for investors seeking exposure to the pharmaceutical industry. Headquartered in Bagsvaerd,..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Unveiling a Potential 90% Upside with Biotech Innovation

Rapport Therapeutics, Inc. (NASDAQ: RAPP), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector with its promising pipeline of treatments targeting central nervous system..

Prothena Corporation (PRTA) Stock Analysis: Unveiling a 145% Upside Potential in Biotech Innovations

Prothena Corporation plc (NASDAQ: PRTA), a dynamic player in the biotechnology sector, presents a tantalizing opportunity for investors seeking exposure to the cutting-edge domain of protein..

Abivax SA (ABVX) Stock Analysis: Exploring a 26.15% Potential Upside Despite Financial Challenges

In the dynamic world of biotechnology, Abivax SA (ABVX) stands out as a promising player with its pioneering approach to treating chronic inflammatory diseases. As a..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 48.51% Potential Upside in Biodefense

Emergent BioSolutions Inc. (NYSE: EBS) stands at an intriguing intersection for investors, particularly those focused on the healthcare sector’s dynamic landscape. Known for its robust portfolio..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds